Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Sevoflurane for Survival in Elderly Cancer Surgery Patients
NCT02660411Completed
- Sponsor
- Peking University First Hospital
- Start
- Apr 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propofol injection (veterinary) in Neoplasm, sponsored by Peking University First Hospital. Primary endpoint: Overall Survival at 5 years. Started Apr 2015; status: completed.
02
Drugs
propofol injection (veterinary)
03
Conditions
Neoplasm
Beyond the preview
Go deeper on NCT02660411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660411.